Surgery Partners, Inc. (NASDAQ:SGRY) – KeyCorp cut their Q3 2017 EPS estimates for Surgery Partners in a research note issued to investors on Tuesday. KeyCorp analyst J. Gurda now expects that the company will post earnings of $0.03 per share for the quarter, down from their previous forecast of $0.21. KeyCorp also issued estimates for Surgery Partners’ Q4 2017 earnings at $0.37 EPS, FY2017 earnings at $0.43 EPS, FY2018 earnings at $0.75 EPS and FY2019 earnings at $1.22 EPS.
A number of other brokerages have also weighed in on SGRY. Raymond James Financial, Inc. restated a “market perform” rating on shares of Surgery Partners in a research report on Wednesday. BidaskClub downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Zacks Investment Research raised shares of Surgery Partners from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a report on Wednesday, August 2nd. Finally, Stifel Nicolaus downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating and lowered their price target for the company from $21.00 to $17.00 in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $21.40.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/2801996/surgery-partners-inc-expected-to-earn-q3-2017-earnings-of-0-03-per-share-sgry.html.
Surgery Partners (SGRY) opened at 10.70 on Friday. Surgery Partners has a 52-week low of $9.20 and a 52-week high of $24.05. The company’s 50-day moving average price is $20.65 and its 200 day moving average price is $20.26. The stock has a market capitalization of $515.15 million, a PE ratio of 70.39 and a beta of 1.71.
Several hedge funds have recently bought and sold shares of the stock. Atria Investments LLC increased its stake in Surgery Partners by 2.3% in the second quarter. Atria Investments LLC now owns 10,627 shares of the company’s stock valued at $242,000 after buying an additional 238 shares in the last quarter. Alliancebernstein L.P. increased its stake in Surgery Partners by 1.1% in the second quarter. Alliancebernstein L.P. now owns 28,400 shares of the company’s stock valued at $646,000 after buying an additional 300 shares in the last quarter. Campbell Newman Asset Management Inc. increased its stake in Surgery Partners by 4.9% in the second quarter. Campbell Newman Asset Management Inc. now owns 12,649 shares of the company’s stock valued at $288,000 after buying an additional 586 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Surgery Partners by 0.3% in the second quarter. Ameriprise Financial Inc. now owns 229,575 shares of the company’s stock valued at $5,223,000 after buying an additional 605 shares in the last quarter. Finally, Parametric Portfolio Associates LLC increased its stake in Surgery Partners by 2.5% in the first quarter. Parametric Portfolio Associates LLC now owns 28,172 shares of the company’s stock valued at $549,000 after buying an additional 689 shares in the last quarter. 39.36% of the stock is owned by hedge funds and other institutional investors.
Surgery Partners Company Profile
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.